Results 41 to 50 of about 6,717 (169)
Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 10, Page 1702-1712, October 2026.A comprehensive retrospective analysis of 121 immune checkpoint inhibitor‐induced eosinophilic fasciitis cases, including clinical presentation, diagnostic features and treatment outcomes using data from the EADV Task Force ‘Dermatology for Cancer Patients’, two international pharmacovigilance databases and the current literature.
Tristan V. M. Bruijn +17 more
wiley +1 more source
Carcinogenic risk of bath PUVA in comparison to oral PUVA therapy
, 1999 The potential carcinogenic risk of bath PUVA therapy was compared to that of systemic (oral) PUVA. An analysis of the epidemiological data on cancer risk following bath PUVA with trimethylpsoralen does not support the conclusion that bath PUVA per se is ...
Shephard, S. E., Panizzon, R. G.
core +1 more source
The PUVA Lentigo: An Analysis of Predisposing Factors [PDF]
, 1983 Pigmented macules appearing in sun-protected sites of psoriatic patients treated chronically with oral methoxsalen photochemotherapy (PUVA) have been characterized as a lentiginous proliferation of relatively large, sometimes cytologically atypical ...
Stern, Robert S. +2 more
core +1 more source
Vestnik Dermatologii i Venerologii, 2017 Goal. To assess the therapeutic efficacy of the rotation of mid-wavelength ultraviolet therapy (311 nm) and PUVA therapy in patients with moderate to severe forms of psoriasis, and to assess the efficacy of mid-wavelength ultraviolet therapy (311 nm) in ...
M. B. Zhilova, V. V. Chikin
doaj +1 more source
JEADV Clinical Practice, Volume 5, Issue 3, Page 917-921, September 2026.ABSTRACT Background Scleromyxedema (SMX) is a cutaneous mucinosis characterised by an abnormal accumulation of mucin in the skin and limited treatment options. Assessment of therapy response during treatment is challenging. Objectives Patients with SMX receiving high‐dose intravenous IVIg therapy were included to assess validity of the double modified ...
Julia K. Winkler, Alexander H. Enk
wiley +1 more source
, 2002 TITELBLATT 1. EINLEITUNG 1 1.1. Psoriasis vulgaris 1 1.2. Biologische Wirkung des Lichtes 11 1.3. Psoralene 14 1.4. Untersuchungsgegenstand 41 2. PATIENTEN, MATERIAL UND METHODEN 43 2.1. Klinische Studie: Dusch-PUVA vs.
Aryee-Boi, Jeannette
core +1 more source
Fototerapija (UVB) i fotokemoterapija (PUVA) u liječenju psorijaze [PDF]
, 2002 The review covers the current practice of phototherapy with ultraviolet (UV) radiation without sensitizers and of psoralen photochemotherapy (PUVA) in the treatment of psoriasis.
Kostović, Krešimir +2 more
core +1 more source
Juvenile Mycosis Fungoides: A Multicenter Retrospective Italian Study
JEADV Clinical Practice, Volume 5, Issue 3, Page 839-845, September 2026.This multicenter retrospective study included 29 juvenile mycosis fungoides (JMF) patients from five Italian centres with confirmed histopathological diagnosis. most often presents with hypopigmented/classic variants and CD8+ phenotype. Early‐onset cases ( < 14 years) show better long‐term outcomes.
Andrea Michelerio +8 more
wiley +1 more source
PUVA Induced Bullous Pemphigoid in a Patient with Mycosis Fungoides
Case Reports in Dermatological Medicine, 2017 Background. Bullous pemphigoid is an autoimmune subepidermal blistering skin disease in which autoantibodies are directed against components of the basement membrane.
Birgül Özkesici +5 more
doaj +1 more source
Brentuximab Vedotin‐Induced Rash Sparing CD30‐Positive Mycosis Fungoides Lesions
JEADV Clinical Practice, Volume 5, Issue 3, Page 971-973, September 2026.Capsule Summary ABSTRACT Brentuximab vedotin (BV) is an effective treatment for CD30‐positive lymphomas, including mycosis fungoides (MF). However, its use can be associated with various cutaneous adverse effects, including rashes. This case describes a 60‐year‐old male with stage IIB MF who developed a drug‐induced erythematous rash after three ...
Isabel Hariri +2 more
wiley +1 more source